Do Patients Who Are Treated With Tranexamic Acid Loose Les Blood, Comparing to Patients Who Are Not Treated, During Vaginal Hysterectomy? a Randomized Control Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a randomized control, double-blind study in which women who are about to go an elective vaginal hysterectomy are offered to participate. Patients will be randomly assigned to one of two groups: the tranexamic acid group, in which 1 gram of tranexamic acid (Hexakapron) is administered intravenously before surgery, and the control group, in which patients will receive 10 ml of normal saline 0.9% intravenously.
Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: t
View:
• \*Women in general good health (defined as American Society of Anesthesiologists grade 1-2) who are about to undergo elective vaginal hysterectomy indicated by pelvic organ prolapse (POP).
Locations
Other Locations
Israel
Wolfson medical center
RECRUITING
Holon
Contact Information
Primary
Ohad Gluck
ohadgluck@gmail.com
0528702255
Time Frame
Start Date: 2023-01-22
Estimated Completion Date: 2025-01-01
Participants
Target number of participants: 80
Treatments
Active_comparator: Tranexamic acid arm
One gram of tranexamic acid (Hexakapron) is administered intravenously before surgery.
Placebo_comparator: Placebo arm
patients will receive 10 ml of normal saline 0.9% intravenously.
Related Therapeutic Areas
Sponsors
Leads: Wolfson Medical Center